Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients

BACKGROUND: Antibody levels against SARS-CoV-2 can be used as an indicator of recent or past vaccination or infection. However, the prognostic value of antibodies targeting the receptor binding protein (anti-RBD) in hospitalized patients is not widely reported. PURPOSE: Determine prognostic impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Madanat, Luai, Sager, Melinda, O’Connor, Daniel, Thapa, Bijaya, Aggarwal, Nishant, Ghimire, Bipin, Lauter, Carl, Maine, Gabriel N, Sims, Matthew, Halalau, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215841/
https://www.ncbi.nlm.nih.gov/pubmed/35755860
http://dx.doi.org/10.2147/IJGM.S370080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215841/
https://www.ncbi.nlm.nih.gov/pubmed/35755860
http://dx.doi.org/10.2147/IJGM.S370080

Ejemplares similares